Considerations for Implementation of Serum Biomarker Testing for Suspected Hypertensive Disorders of Pregnancy
This review aims to outline clinical and institutional considerations for placental biomarker utilization in the context of their FDA-approved uses and to highlight the potential advantages and disadvantages of various testing strategies.
Authors
- Megan C. Oakes (ORCID: https://orcid.org/0000-0001-9356-9375)
- Christina Frasik
- Ashten Waks (ORCID: https://orcid.org/0000-0003-3826-3714)
Institutions
- University of California, Irvine (US)
- MemorialCare Long Beach Medical Center (US)
- University of California, Irvine Medical Center (US)
- Miller Children's & Women's Hospital (US)
Publication Details
- Journal
- Clinical Chemistry
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1093/clinchem/hvaf115
- Primary Topic
- Pregnancy and preeclampsia studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00